Replimune Group
REPL • NASDAQ • Stock Fundamentals
Replimune Group is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sushil Patel, with a market cap of $379.8M.
Market Cap$379.8M
Employees331.0
CEOSushil Patel
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsFeb 3, 2026 · 3 months 25 days agoQ4 2025
View reportNext EarningsJul 30, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q4 2025 filing
Replimune Group FAQ
Common questions about Replimune Group
Replimune Group (REPL) has a market capitalization of $379.8M and trades on NASDAQ.
Replimune Group has approximately 331 employees.